This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anygen Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ye Ga Park: Innovator in Diabetes Treatment
Introduction
Ye Ga Park is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on creating novel substances that improve the stability and efficacy of diabetes medications.
Latest Patents
Ye Ga Park holds 1 patent for his invention titled "Exenatide analog and use thereof." This patent pertains to an exenatide analogue that is glycosylated to a specific residue. The invention provides a novel substance for treating diabetes, exhibiting improved in vivo stability compared to conventional exenatides and their analogues. Additionally, the patent includes an exenatide dimer analogue, which also offers significant improvements in treating diabetes and obesity.
Career Highlights
Ye Ga Park is associated with Anygen Co., Ltd., where he continues to advance his research in diabetes treatment. His work has garnered attention for its potential to enhance the quality of life for individuals living with diabetes.
Collaborations
Some of his notable coworkers include Jae Ha Ryu and Sang Hyun Joo, who contribute to the innovative environment at Anygen Co., Ltd.
Conclusion
Ye Ga Park's contributions to diabetes treatment through his patented inventions highlight the importance of innovation in healthcare. His work exemplifies the potential for scientific advancements to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile